Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

834
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
834
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

1.8K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.8K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

547
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
547
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

420
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
420

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The importance of choosing a proper validation strategy in predictive models. Part 2: Recipes for (avoiding) overfitting-A tutorial.

Analytica chimica acta·2026
Same author

Meeting of the International Association for Spectral Imaging IASIM-2024: Bilbao, Spain, 6th - 10th July, 2024.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

Challenges and spectra interpretability in textile sorting: NIR hyperspectral images and chemometrics.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

Visualization and quantification of citalopram hydrobromide within highly porous drug products by near-infrared chemical imaging.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Same author

Analysis and interpretation of organic compounds in Martian meteorites with Raman imaging and chemometrics.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

ARCHER. A new algorithm for automatic removal of cosmic spikes and saturated pixels in hyperspectral Raman spectroscopy.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025

Related Experiment Video

Updated: May 1, 2026

Excitation-Scanning Hyperspectral Imaging Microscopy to Efficiently Discriminate Fluorescence Signals
07:34

Excitation-Scanning Hyperspectral Imaging Microscopy to Efficiently Discriminate Fluorescence Signals

Published on: August 22, 2019

7.3K

Practical issues of hyperspectral imaging analysis of solid dosage forms.

José Manuel Amigo1

  • 1Department of Food Science Quality and Technology, Faculty of Life Sciences, University of Copenhagen, Rolighedsvej 30, 1958 Frederiksberg C, Denmark. jmar@life.ku.dk

Analytical and Bioanalytical Chemistry
|May 25, 2010
PubMed
Summary

Hyperspectral imaging provides valuable chemical and spatial data for pharmaceutical solid dosage forms. This review discusses the advantages and challenges of using these techniques in drug development.

More Related Videos

Hyperspectral Imaging as a Tool to Study Optical Anisotropy in Lanthanide-Based Molecular Single Crystals
07:24

Hyperspectral Imaging as a Tool to Study Optical Anisotropy in Lanthanide-Based Molecular Single Crystals

Published on: April 14, 2020

17.4K
Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
07:05

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section

Published on: June 20, 2025

1.6K

Related Experiment Videos

Last Updated: May 1, 2026

Excitation-Scanning Hyperspectral Imaging Microscopy to Efficiently Discriminate Fluorescence Signals
07:34

Excitation-Scanning Hyperspectral Imaging Microscopy to Efficiently Discriminate Fluorescence Signals

Published on: August 22, 2019

7.3K
Hyperspectral Imaging as a Tool to Study Optical Anisotropy in Lanthanide-Based Molecular Single Crystals
07:24

Hyperspectral Imaging as a Tool to Study Optical Anisotropy in Lanthanide-Based Molecular Single Crystals

Published on: April 14, 2020

17.4K
Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
07:05

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section

Published on: June 20, 2025

1.6K

Area of Science:

  • Pharmaceutical Sciences
  • Analytical Chemistry
  • Spectroscopy

Background:

  • Hyperspectral imaging (HSI) has emerged as a powerful tool in pharmaceutical research.
  • Middle infrared (MIR), near-infrared (NIR), and Raman spectroscopy are key HSI techniques.
  • HSI offers robust chemical and spatial information for solid dosage forms.

Purpose of the Study:

  • To review the advantages and drawbacks of HSI techniques in pharmaceutical solid dosage form development.
  • To discuss instrumentation and data analysis considerations for HSI in this field.

Main Methods:

  • Review of hyperspectral imaging techniques (MIR, NIR, Raman).
  • Discussion of data processing and analysis methods.
  • Evaluation of instrumentation for surface scanning and analysis.

Main Results:

  • HSI provides detailed chemical and spatial distribution of components in solid dosage forms.
  • Combination of HSI devices and data processing enables advanced surface analysis.
  • Instrumentation and data analysis present challenges that require careful consideration.

Conclusions:

  • Hyperspectral imaging is a valuable technique for pharmaceutical solid dosage form development.
  • Understanding the advantages and limitations of HSI is crucial for successful application.
  • Further development in instrumentation and data analysis will enhance HSI utility in drug development.